Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio ranging from 1:10 to 1:100, with the exact ratio to be determined by the Board. The proposal passed with 1,152,016 votes in favor against 142,944 opposed. iSpecimen Inc. operates in the healthcare sector, providing digital pathology solutions.
